Zobrazeno 1 - 10
of 10
pro vyhledávání: '"E Guarc Prades"'
Publikováno v:
Revista Clínica Española. 217:304-306
Publikováno v:
Revista clinica espanola. 217(5)
Autor:
B Bonaga Serrano, MA Alcácera López, B Abad Bañuelos, I Puértolas Tena, B Amores Arriaga, M Merchante Andreu, T Salvador Gómez, E Guarc Prades, M Gimeno Gracia
Publikováno v:
European Journal of Hospital Pharmacy. 23:A241.2-A242
Background The emergency departments have operating characteristics that make them especially prone to the occurrence of medication errors (ME). These units represent one of the departments with the highest incidence of errors with serious outcomes.
Autor:
E Guarc Prades, E Fernández Alonso, MJ Cumbraos Sánchez, MP Pardo Jario, M Merchante Andreu, M.A. Allende Bandrés, T Salvador Gómez, MA Alcácera López
Publikováno v:
European Journal of Hospital Pharmacy. 22:A190.1-A190
Background In June 2013, it was decided to start a protocol for the use of ranibizumab. Patients were grouped in order to fractionate vials in 0.5 ml syringes as a savings strategy under aseptic conditions. 3 doses of ranibizumab suitable for use are
Autor:
E Aurensanz Clemente, M Gimeno Gracia, M. Sanchez Berriel, E Guarc Prades, A Alcácera López, E Fernández Alonso
Publikováno v:
European Journal of Hospital Pharmacy. 21:A28.1-A28
Background A lack of adherence to antiretroviral treatment (ART) is the main cause of treatment failure in both children and adults, and it is particularly important in adolescents. Purpose To determine the adherence to ART in HIV-infected children.
Autor:
MA Alcácera López, M. Arenere Mendoza, P. Arrabal Torcal, M.A. Allende Bandrés, E Guarc Prades, M Gimeno Gracia
Publikováno v:
European Journal of Hospital Pharmacy. 19:159.2-159
Background The expenditure on drugs represents a significant part of hospital budgets. Purpose To analyse changes in hospital pharmaceutical expenditure in HCU ‘Lozano Blesa’ during 2006-2010. Materials and methods Retrospective study of drug con
Autor:
E Guarc Prades, MA Alcácera López, M. Sanchez Berriel, M.A. Allende Bandrés, M. Arenere Mendoza, M Gimeno Gracia
Publikováno v:
European Journal of Hospital Pharmacy. 19:208.1-208
Background One of the prescribing quality indicators (PQI) set by the program contract for specialised care (SC) in our sector is the prescription by active substance (AS) instead of prescribing by brand name. Purpose To improve the quality and effic
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Brandariz Núñez D; Servicio de Farmacia Hospitalaria, Hospital Quironsalud Barcelona, Barcelona.. vrandariz@gmail.com., Guarc Prades E; Servicio de Farmacia Hospitalaria, Hospital Quironsalud Barcelona, Barcelona.. eva.guarc@quironsalud.es., García Navarro B; Servicio de Farmacia Hospitalaria, Hospital Quironsalud Barcelona, Barcelona.. barbara.gracia@quironsalud.es., Picón Herrera R; Servicio de Farmacia Hospitalaria, Hospital Quironsalud Barcelona, Barcelona.. rafael.picon@quironsalud.es., Hernandez Corredoira V; Servicio de Farmacia Hospitalaria, Hospital Quironsalud Barcelona, Barcelona.. virginia.hernandez@quironsalud.es.
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria [Farm Hosp] 2018 Jan 01; Vol. 42 (1), pp. 31-32. Date of Electronic Publication: 2018 Jan 01.